23.00.00	ELECTRONIC PRESCRIPTION DRUG MONITORING PROGRAM
23.00.10	Definitions:
	a.	“Prescription Drug Outlet” means any resident or nonresident pharmacy registered with the Colorado State Board of Pharmacy.
	b.	“PDMP” means the Electronic Prescription Drug Monitoring Program.
23.00.20	Submission Requirement.
All prescription drug outlets shall submit their controlled substance dispensing transactions for Schedule II, III, IV, and V Controlled Substances to the PDMP with the exception of the following:
	a.	Hospitals licensed or certified pursuant to CRS 25-1.5-103 that dispense no more than a 24-hour supply of a controlled substance to an outpatient; or
	b.	Hospitals licensed or certified pursuant to CRS 25-1.5-103 which dispense controlled substances only pursuant to chart orders; or
	c.	A prescription drug outlet which has applied to the Board and received a waiver from the Prescription Controlled Substance Abuse Monitoring Advisory Committee.  Waivers will only be considered if the pharmacy has no electronic automation.
23.00.30	Data Submission Timeline.
Every prescription drug outlet must ensure controlled substance dispensing transactions are reported to the PDMP twice each month on the following schedule: 
	a.	For dispensing transactions from the first through the 15th day of each month, data shall be transmitted to the PDMP between the 16th and 25th day of that month.
	b.	For dispensing transactions from the 16th through the last day of the month, data shall be transmitted to the PDMP between the 1st through the 10th day of the subsequent month.
	c.	If the prescription drug outlet does not dispense any controlled substances for the reporting period, it must enter a “zero” entry or will be considered non-compliant.
23.00.40	Data Submission Format.
Prescription drug outlets shall submit to the PDMP the following data requirements:
a.	Identifier (Transmission type identifier), if applicable;
b	Bin (Bank Identification Number);
c	Version Number (a number to identify the format of the transaction sent or received);
d.	Transaction Code;
e.	NABP or DEA number assigned to pharmacy;
f.	Customer ID (number to identify the patient receiving the RX);
g.	Zip Code (3 digit US Postal Code identifying the State Code), if applicable; 
h.	Customer’s Birth Date;
i.	Sex Code;
j.	Date Filled;
k.	Prescription Number;
l.	New/Refill Number;
m.	Metric Quantity;
n.	Days Supply;
o.	Compound Code;
p.	NDC Number of the drug dispensed;
q.	Prescriber’s DEA registration;
r.	DEA suffix, if applicable;
s.	Date RX Written;
t.	Number of Refills Authorized;
u.	RX Origin Code;
v.	Customer Location;
w.	Diagnosis Code, if available;
x.	Alternate Prescriber #, if applicable;
y.	Patient Last Name;
z.	Patient First Name;
aa.	Patient Street Address;
bb.	Patient’s state of residence;
cc.	Patient’s zip code;
dd.	Triplicate Serial Number, if appropriate; and
ee.	Filler Field to be populated with Payment Type as designated by PDMP vendor.

23.00.50	Data Correction.
	a.	Any errors identified by the PDMP shall be corrected and resubmitted by the prescription drug outlet on the following schedule:
	1.	For dispensing transactions from the 1st through the 15th day of each month, errors shall be corrected no later than the first day of the following month.
	2.	For dispensing transactions from the 16th through the 31st of each month, errors shall be corrected no later than the 16th day of the following month.
	b.	If errors cannot be corrected, the pharmacy must retain a record in written format detailing the following information for each uncorrected error:
	1.	Detail of Error Notification highlighting uncorrected error(s); and
	2.	Detailed reason of why error cannot be corrected.